Pillstats
Rx only · Capsule · Oral

Ranitidine Hydrochloride

Ranitidine Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)9143
US makers1 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Dr.Reddy's laboratories Limitedunknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 1, 2019
    RECALLRecall (Class II): Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-1…

    CGMP Deviations: Presence of NDMA impurity detected in product. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Product was distributed to major distributors throughout the United States who may have further distributed the product.

  • Oct 1, 2019
    RECALLRecall (Class II): Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (NDC 55111-1…

    CGMP Deviations: Presence of NDMA impurity detected in product. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Product was distributed to major distributors throughout the United States who may have further distributed the product.